Skip to main content

Advertisement

Log in

Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn’s Disease

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. George LA, Gadani A, Cross RK, et al. Psoriasiform skin lesions are caused by anti-TNF agents used for the treatment of inflammatory bowel disease. Dig Dis Sci. 2015;60:3424–3430.

    Article  CAS  PubMed  Google Scholar 

  2. Afzali A, Wheat LC, Huc JK, et al. The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series. J Crohn’s Colitis. 2014;8:480–488.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eren Cankurtaran.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cankurtaran, E., Ekiz, F., Hamamci, M. et al. Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn’s Disease. Dig Dis Sci 61, 1206–1207 (2016). https://doi.org/10.1007/s10620-016-4072-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4072-y

Keywords

Navigation